PAS 2090:2025 - Pharmaceutical Products: Product Category Rules for Life Cycle Assessments

Introducing the PAS 2090:2025, a comprehensive standard that sets the benchmark for conducting life cycle assessments (LCAs) in the pharmaceutical industry. This specification is an essential tool for professionals seeking to enhance the sustainability and environmental performance of pharmaceutical products.

Overview

The PAS 2090:2025 is a meticulously crafted standard that provides detailed product category rules (PCRs) specifically tailored for the pharmaceutical sector. Released on November 27, 2025, this standard is designed to guide organizations in performing accurate and consistent LCAs, ensuring that the environmental impacts of pharmaceutical products are thoroughly assessed and minimized.

Key Features

• Standard Number: PAS 2090:2025
• Pages: 84
• ISBN: 978 0 539 39306 4
• Status: Standard

Why Choose PAS 2090:2025?

The pharmaceutical industry is under increasing pressure to reduce its environmental footprint. The PAS 2090:2025 provides a structured approach to LCAs, enabling companies to identify and mitigate environmental impacts throughout the product life cycle. By adhering to this standard, organizations can:

• Enhance Sustainability: Implementing the guidelines of PAS 2090:2025 helps in reducing waste, conserving resources, and minimizing emissions, contributing to a more sustainable future.
• Improve Compliance: Stay ahead of regulatory requirements and industry standards by adopting a recognized framework for environmental assessment.
• Boost Brand Reputation: Demonstrating a commitment to environmental responsibility can enhance brand image and customer trust.
• Drive Innovation: Encourages the development of innovative solutions to reduce environmental impacts, fostering a culture of continuous improvement.

Comprehensive Guidance

With 84 pages of in-depth content, the PAS 2090:2025 offers comprehensive guidance on conducting LCAs for pharmaceutical products. It covers all stages of the product life cycle, from raw material extraction to manufacturing, distribution, use, and end-of-life disposal. This holistic approach ensures that all potential environmental impacts are considered and addressed.

Who Should Use This Standard?

The PAS 2090:2025 is an invaluable resource for a wide range of stakeholders in the pharmaceutical industry, including:

• Environmental Managers: Responsible for overseeing sustainability initiatives and ensuring compliance with environmental regulations.
• Product Developers: Engaged in the design and development of pharmaceutical products, seeking to incorporate sustainable practices.
• Quality Assurance Professionals: Ensuring that products meet both quality and environmental standards.
• Regulatory Affairs Specialists: Navigating the complex landscape of environmental regulations and standards.

Conclusion

The PAS 2090:2025 is more than just a standard; it is a strategic tool for driving sustainability in the pharmaceutical industry. By adopting this specification, organizations can not only improve their environmental performance but also gain a competitive edge in an increasingly eco-conscious market. Equip your team with the knowledge and framework needed to excel in life cycle assessments and make a positive impact on the environment.

PAS 2090:2025

This standard PAS 2090:2025 Pharmaceutical products. Product category rules for life cycle assessments. Specification is classified in these ICS categories:

• 13.020.01 Environment and environmental protection in general
• 13.020.60 Product life-cycles
• 11.120.01 Pharmaceutics in general